Pancreatic Cancer Trial, Recruiting NCT07659639 Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT07659639
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have not previously been diagnosed with any type of cancer or tumour
  • People whose kidneys and liver are functioning well enough to meet the trial's health requirements
  • People who do not have any blood or bone marrow disorders
  • People who are 18 years of age or older
  • People who do not have any active infections at the time of joining
  • People who are willing and able to provide written consent to participate

Who may not be able to join:

  • People who have serious existing health conditions that could affect the trial's results or put their health at significant risk
  • People who are currently receiving treatments or therapies that could interfere with the trial or affect its results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +3906225418012

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
1 August 2029

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Diagnostic Accuracy of the Biophotonic Nanoparticle-Enabled Laser Blood Test (LASERBLOOD) for Detection of Pancreatic Ductal Adenocarcinoma (PDAC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov